SRRKScholar Rock Holding Corporation

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M-24.8% YoY

Gross Profit

-$59M-380.8% margin

Operating Income

-$87M-564.0% margin

Net Income

-$86M-561.5% margin

EPS (Diluted)

$-2.77

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$64M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$388M

Total Liabilities

$128M

Stockholders' Equity

$261M

Cash & Equivalents

$160M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$20M	-24.8%
Gross Profit	-$59M	-$34M	-73.9%
Operating Income	-$87M	-$55M	-59.3%
Net Income	-$86M	-$51M	-69.6%

SRRK FY 2020 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena